Search by Drug Name or NDC
NDC 00113-0791-34 tussin dm 20; 200 mg/10mL; mg/10mL Details
tussin dm 20; 200 mg/10mL; mg/10mL
tussin dm is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by L. Perrigo Company. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 00113-0791-34Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 00113-0791-34Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 00113-0791 |
---|---|
Product ID | 0113-0791_0226c6f9-c974-4aec-b524-7ff09bdbaf0d |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | tussin dm |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Dextromethorphan HBr, Guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | SOLUTION |
Route | ORAL |
Active Ingredient Strength | 20; 200 |
Active Ingredient Units | mg/10mL; mg/10mL |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | L. Perrigo Company |
Pharmaceutical Class | Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | 2023-12-31 |
Package
Package Images

NDC 00113-0791-34 (00113079134)
NDC Package Code | 0113-0791-34 |
---|---|
Billing NDC | 00113079134 |
Package | 1 BOTTLE in 1 CARTON (0113-0791-34) / 237 mL in 1 BOTTLE |
Marketing Start Date | 2018-01-09 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 686bd5a5-5d30-4993-b51e-d6dd8f7af16a Details
Uses
Warnings
Do not use
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- •
- cough that occurs with too much phlegm (mucus)
- •
- cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema
Directions
- •
- do not take more than 6 doses in any 24-hour period
- •
- measure only with dosing cup provided
- •
- keep dosing cup with product
- •
- mL = milliliter
- •
- this adult product is not intended for use in children under 12 years of age
age |
dose |
adults and children 12 years and over |
10 mL every 4 hours |
children under 12 years |
do not use |
Other information
Inactive ingredients
Principal Display Panel
INGREDIENTS AND APPEARANCE
TUSSIN DM
dextromethorphan hbr, guaifenesin solution |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
Labeler - L. Perrigo Company (006013346) |